THANZ Symposium: HHT: From breakthroughs to better care
Tracks
THANZ
| Monday, October 19, 2026 |
| 2:00 PM - 3:30 PM |
| 516 |
Speaker
Dr Hanny Al-Samkari
The Peggy S. Blitz Endowed Chair in Hematology/Oncology; Associate Professor of Medicine
Harvard Medical School/Massachusetts General Hospital
A paradigm shift in treatment of the second most common inherited bleeding disorder: Advances in systemic therapy of HHT
2:00 PM - 2:30 PMBiography
Dr. Hanny Al-Samkari is the Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. He is a classical hematologist and NIH-funded clinical investigator and clinical trialist. He also serves as Co-Director the MGH Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence. His clinical and research interests are in hemostasis, thrombosis and hemolysis, with focuses in HHT, immune thrombocytopenia, and hemolytic anemias. As a clinical investigator, Dr. Al-Samkari is an internationally recognized expert in the clinical development of novel therapeutics for these disorders and serves as the lead principal investigator for multiple ongoing clinical trials. He is the emeritus Executive Editor of Hematology: The ASH Education Program, an American Society of Hematology peer-reviewed publication, and a current Associate Editor of the Journal of Thrombosis and Haemostasis, the flagship journal of the International Society on Thrombosis and Haemostasis. He has published over 180 peer-reviewed manuscripts. His original research has been featured in The New England Journal of Medicine, The Lancet, Annals of Internal Medicine and Blood, among other top peer-reviewed journals in hematology and medicine.
Dr Tom Sapsford
Haematologist
Health New Zealand Waitemata
HHT Aotearoa - early success but much to do
2:30 PM - 3:00 PMBiography
Tom is a clinical haematologist working at Te Whatu Ora Waitemata in Auckland. His main clinical focus is on myeloma and lymphoma, with special interests in HHT, medical education and systems optimisation.
Assoc Prof Philip Choi
Senior Staff Specialist
The Canberra Hospital
Understanding the impact of HHT in Australia and New Zealand: The case for an HHT registry
3:00 PM - 3:30 PMBiography
Philip Choi is an Associate Professor at ANU and Senior Staff Specialist at The Canberra Hospital, Clinical Director of the National Platelet Research and Referral Centre (NPRC), Principal Clinical Haematology Editor of Platelets, Platelet Disorders Theme Leader ISTH 2026, and former co-chair of the Platelet Immunology Subcommittee of the ISTH.
Dr Charithani Keragala
Haematologist
Monash Health
Chairperson
Biography
Dr Tom Sapsford
Haematologist
Health New Zealand Waitemata
Chairperson
Biography
Tom is a clinical haematologist working at Te Whatu Ora Waitemata in Auckland. His main clinical focus is on myeloma and lymphoma, with special interests in HHT, medical education and systems optimisation.
